Publications by authors named "Shanliang Hu"

Claim this Profile
M
Metagenomics-Metabolomics Reveals the Alleviation of Indole-3-Ethanol on Radiation-Induced Enteritis in Mice.
Hua Zhong, Yipeng Song, Shanliang Hu, Chengxu Zhang, Lili Li

J Microbiol Biotechnol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anlotinib as Maintenance Therapy After First-Line Chemotherapy Combined with Consolidation Radiation for Extensive-Stage Small Cell Lung Cancer.
Jinbo Ma, Xiaoyan Ma, Wei Zhang, Shanliang Hu, Rukun Zang

Technol Cancer Res Treat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a prognostic nomogram model in locally advanced NSCLC based on metabolic features of PET/CT and hematological inflammatory indicators.
Congjie Wang, Jian Fang, Tingshu Jiang, Shanliang Hu, Ping Wang, Shenchun Zou

EJNMMI Phys· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis.
Chunsheng Wang, Kewei Zhao, Shanliang Hu, Wei Dong, Yan Gong, Conghua Xie

Oncologist· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alginate oligosaccharide ameliorates azithromycin-induced gut microbiota disorder -FAHFAs and -TCA cycle axes.
Shuling Yan, Yanhong Zhu, Lili Li, Song Qin, Jingyi Yuan, Shanliang Hu

Food Funct· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inconsistent clinical outcomes following afatinib treatment in NSCLC patients harboring uncommon epidermal growth factor receptor mutation.
Wei Dong, Congjie Wang, Chunsheng Wang, Kewei Zhao, Zhao Ma, Shanliang Hu

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of gefitinib and erlotinib in patients with NSCLC harboring uncommon EGFR mutations: A pooled analysis of 438 patients.
Chunsheng Wang, Kewei Zhao, Shanliang Hu, Wei Dong, Yan Gong, Minghuan Li, Conghua Xie

Lung Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-phycocyanin alleviated cisplatin-induced oxidative stress and inflammation gut microbiota-metabolites axis in mice.
Yubing Zhang, Lili Li, Song Qin, Jingyi Yuan, Xiaonan Xie, Shanliang Hu

Front Nutr· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoration of cefixime-induced gut microbiota changes by a prebiotic blend in a mouse model.
Jingyi Yuan, Song Qin, Shanliang Hu, Zhengyi Liu, Yipeng Song

Appl Microbiol Biotechnol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insensitivity to T790M mutation? A pooled analysis of outcomes following osimertinib for the treatment of NSCLC patients harboring uncommon epidermal growth factor receptor mutation.
Shanliang Hu, Congjie Wang, Chunsheng Wang, Kewei Zhao, Zhen Wang

Front Pharmacol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alginate Oligosaccharide Alleviated Cisplatin-Induced Kidney Oxidative Stress Genus-FAHFAs-Nrf2 Axis in Mice.
Yubing Zhang, Song Qin, Yipeng Song, Jingyi Yuan, Shanliang Hu

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gut microbiota and its products: Establishing causal relationships with obesity related outcomes.
Lili Li, Yubing Zhang, John Roger Speakman, Shanliang Hu, Yipeng Song

Obes Rev· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and Treatment Strategies of Osimertinib Resistance in T790M-Positive Non-Small Cell Lung Cancer: A Pooled Analysis.
Chunsheng Wang, Kewei Zhao, Shanliang Hu, Minghuan Li, Yipeng Song

Front Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PET-Derived Tumor-to-Liver Standard Uptake Ratio (SUV ) Is Superior to Tumor SUVmax in Predicting Tumor Response and Survival After Chemoradiotherapy in Patients With Locally Advanced Esophageal Cancer.
Chunsheng Wang, Kewei Zhao, Shanliang Hu, Yong Huang, Li Ma, Minghuan Li

Front Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR.
Chunsheng Wang, Kewei Zhao, Shanliang Hu, Yong Huang, Li Ma, Minghuan Li

BMC Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly expressed microRNA-124 inhibits migration and promotes apoptosis of esophageal cancer cells by degrading PDCD6.
Shanliang Hu, Rukun Zang, Yang Wang, Yingchao Liang, Junjun Mu

J BUON· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis